Green Thumb Industries (GTII) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
18 May, 2026Market landscape and growth outlook
U.S. cannabis market projected to reach $100B by 2030, rivaling alcohol and tobacco industries in size.
Cannabis industry expected to grow at a 12% CAGR through 2027, outpacing beer, tobacco, spirits, and wine.
Social and legislative momentum is strong, with 64% of Americans supporting legalization and multiple states expanding access since 2022.
Legal cannabis generates more tax revenue than alcohol in established markets and supports over 440,000 jobs, surpassing several traditional sectors.
Company overview and strategy
Operates 110+ retail stores across 14 states, serving half of U.S. adults, with 20 manufacturing facilities.
Focuses on high-demand, limited-supply markets, building trusted brands, and disciplined capital allocation.
Brand portfolio includes RYTHM, incredibles, Dogwalkers, Beboe, Señorita, Shine, Doctor Solomon's, and Good Green.
Mission centers on promoting well-being through cannabis, with values of humility, hard work, gratitude, transparency, and integrity.
Brand and retail experience
Data-driven brand portfolio with leading market share in flower (42%), pre-rolls (27%), and beverages (12%), all showing double-digit growth.
RISE retail brand features omni-channel innovation, loyalty programs, and a focus on consumer experience and operational efficiency.
Pipeline of licenses supports continued retail expansion and consistent national branding.
Latest events from Green Thumb Industries
- Q1 2026 revenue up 7.5% to $300.2M, strong cash flow, and expanded share buybacks.GTII
Q1 202613 May 2026 - Revenue up 1.4% to $280M, but net income and margins declined amid price compression.GTII
Q1 202523 Apr 2026 - Q3 revenue up 4% to $287M, Adjusted EBITDA margin 31.1%, strong cash flow and liquidity.GTII
Q3 202423 Apr 2026 - Revenue rose 3.4% in 2025, with strong cash flow and retail expansion offset by margin pressure.GTII
Q4 202525 Feb 2026 - Q2 revenue up 4.7% to $293.3M, but margins pressured by price compression and regulatory headwinds.GTII
Q2 20253 Feb 2026 - Q2 revenue up 11% to $280M, net income $21M, adjusted EBITDA $94M; strong retail growth.GTII
Q2 20242 Feb 2026 - Record revenue, EBITDA, and cash flow drive growth amid pricing and regulatory challenges.GTII
Q4 202423 Dec 2025 - All resolutions, including board elections and plan amendments, passed with no shareholder questions.GTII
AGM 202516 Dec 2025 - Q3 2025 saw modest revenue growth, strong cash flow, and continued share repurchases.GTII
Q3 20255 Nov 2025